关注
Heba Mohammed Hesham
Heba Mohammed Hesham
Ain Shams university
在 pharma.asu.edu.eg 的电子邮件经过验证
标题
引用次数
引用次数
年份
Chimeric HDAC inhibitors: Comprehensive review on the HDAC‐based strategies developed to combat cancer
HM Hesham, DS Lasheen, KAM Abouzid
Medicinal research reviews 38 (6), 2058-2109, 2018
1382018
Design, synthesis, molecular docking study, and biological evaluation of salicylaldimine derivatives as potential histone deacetylases inhibitors (HDACi) and anticancer agents
HM Hesham, DS Lasheen, KAM Abouzid
Archives of Pharmaceutical Sciences Ain Shams University 2 (1), 1-15, 2018
12018
FLT3-PROTACs for combating AML resistance: Analytical overview on chimeric agents developed, challenges, and future perspectives
DAAEE Heba M. Hesham , Eman M.E. Dokla , Eman Z. Elrazaz , Deena S. Lasheen
European Journal of Medicinal chemistry 277, 2024
2024
系统目前无法执行此操作，请稍后再试。
文章 1–3
共建清朗的网络空间,如遇有害信息,请举报。
本站数据皆整合自互联网公开资源索引,方便科研学术方面查询,并不存储相关数据资源;如对此有异议,请联系我们解决.
© 2023 学术资源搜索   @联系我们 | 申请短期会员 | 数据源提交